Moleculight Secures Financing From Bdc Canada And Igan Partners To Support Its Commercial Expansion
08/11/22, 10:13 AM
Location
torontoIndustry
biotechnology
health care
MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DXTM devices. Leonard Kofman and Jody Staggs, Managing Director of SWK Holdings will join MolecuLight's Board of Directors as observers.
Company Info
Location
sidney street
toronto, ontario, canada
Additional Info
MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight